/
Login
Analysis Scores
Damodaran ?
55/100
ROIC banka/finans için tanımsız — mevduat/prim fonlaması borç değil hammaddedir; değerleme öz-sermaye (P/DD) tabanlı yapılır
Dalio Risk ?
91/100
Piotroski ?
4/9
Neutral
Current ratio data missing (C6); gross profit, prev year gross profit data missing → margin comparison unavailable (C8); Banka/finans: kaldıraç/cari-oran/marj kriterleri uygulanamaz, skor kalan kriterlere göre normalize edildi
Graham ?
p10.8
Pahalı
Active Metric?
3/4
Confidence?
69%
Valuation
Potential?
+29.0%
DCF Value ?
5.12
Debt Cycle?
Early Expansion
Data
Data ?
3086
2014-06-05 → 2026-08-19
Risk Analysis (VaR)
Orta
252 days
Annual Volatility ?
%26.4
VaR 95% ?
%2.75
daily max loss
VaR 99% ?
%3.89
daily max loss
CVaR 95% ?
%4.03
expected loss (tail)
Max Drawdown ?
%24.8
30.12.2025 → 13.05.2026
Skewness ?
-1.09
Parametrik%2.75
Historik%2.42
Cornish-Fisher%3.01
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Downtrend
Price (508.50), TRAMA-99 line's %7.6 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 508.5
TRAMA: 550.3215
Difference: %-7.6
Profitability
Net Profit Margin
%42.8
Net profit margin %42.8 — very strong. Compared to previous quarter +0.0 point increase.
ROE – Özkaynak Getirisi (TTM)
%6.2
ROE %6.2 — low return on equity.
Free Cash Flow Margin (TTM)
%31.5
TTM Free Cash Flow is %31.5'i. Strong FCF generation — profit quality is high.
Valuation
P/E Ratio
6.0x
Sector: 14.6x
F/K 6.0x — sector median's (14.6x) %59 below. Attractive for value investing.
P/B Ratio
0.75x
Sector: 1.61x
PD/DD 0.75x — sector median's (1.61x) çok below. Defter değerine göre undervalued.
Indebtedness
Debt / Equity
0.87x
Borç/Özkaynak 0.87x — moderate financial leverage.
Growth
Revenue Growth (YoY)
%+0.5
Revenue YoY %0.5 grew — positive but slow growth.
Net Profit Growth (YoY)
%-7.3
Net profit YoY %-7.3 declined — profitability under pressure.
Score Explanations
Lothien Robustness
71/100
Very strong robustness score (71/100). Damodaran valuation, Dalio risk analysis and balance sheet quality criteria are largely met.
Very Strong
Potential
+29.0%
Plus %29.0 expected value (656.11) vs current price comparison. 3/4 valuation models give 'BUY' signal. Model confidence %69.
Components: PE target: 1227.62 | P/B target: 1128.28 | DCF target: 127.12
Damodaran Valuation
55/100
Moderate Damodaran score (55/100). Value creation capacity limited. Minusk/sorunlu: ROIC banka/finans için tanımsız — mevduat/prim fonlaması borç değil hammaddedir; değerleme öz-sermaye (P/DD) tabanlı yapılır.
Moderate
Dalio Risk Analysis
91/100
Low debt risk (91/100).
Leverage: 50/100 | Debt Service: 50/100 | Quality: 91/100
DCF Discounted Cash Flow
5.12
DCF (5.12) current price %99.0 below — cash flows do not support current price.
Current price: 508.50
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
4/9
Weak Piotroski (4/9). Many balance sheet quality criteria not met. Note: Current ratio data missing (C6); gross profit, prev year gross profit data missing → margin comparison unavailable (C8)
Neutral
Graham Intrinsic Value
p10.8
Graham intrinsic value: p10.8. Pahalı
Expensive
⚖️ Sector Comparison
P/E Ratio
6.0x
vs 14.6x
Sector mediannın %59 below — cheap
P/B Ratio
0.75x
vs 1.61x
Compared to sector %54 cheaper (by book value)
Charts
Indicators
BB deviation
?
RSI thresholds
?
OSB — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.